Literature DB >> 12030713

Exogenous surfactant in acute respiratory distress syndrome: more is better.

A Anzueto.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12030713     DOI： 10.1183/09031936.02.00284902

Source DB:  PubMed          Journal:  Eur Respir J        ISSN： 0903-1936            Impact factor:   16.671


× No keyword cloud information.
  8 in total

1.  Inhibition of pulmonary surfactant adsorption by serum and the mechanisms of reversal by hydrophilic polymers: theory.

Authors:  Joseph A Zasadzinski; T F Alig; Coralie Alonso; Jorge Bernardino de la Serna; Jesus Perez-Gil; H William Taeusch
Journal:  Biophys J       Date:  2005-07-08       Impact factor: 4.033

2.  Protocatechuic acid attenuates lipolysaccharide-induced acute lung injury.

Authors:  Miaomiao Wei; Xiao Chu; Lanxiang Jiang; Xiaofeng Yang; Qinren Cai; Chaochao Zheng; Xinxin Ci; Mingfeng Guan; Juxiang Liu; Xuming Deng
Journal:  Inflammation       Date:  2012-06       Impact factor: 4.092

Review 3.  [Value of surfactant replacement therapy in the treatment of acute respiratory distress syndrome].

Authors:  S Lauer; L G Fischer; H D Stubbe; H Van Aken; M Westphal
Journal:  Anaesthesist       Date:  2006-04       Impact factor: 1.041

4.  Phosphatidylglycerol and surfactant: A potential treatment for COVID-19?

Authors:  Wendy B Bollag; Joyce N Gonzales
Journal:  Med Hypotheses       Date:  2020-09-16       Impact factor: 1.538

Review 5.  Can biomarkers of extracellular matrix remodelling and wound healing be used to identify high risk patients infected with SARS-CoV-2?: lessons learned from pulmonary fibrosis.

Authors:  D J Leeming; F Genovese; J M B Sand; D G K Rasmussen; C Christiansen; G Jenkins; T M Maher; J Vestbo; M A Karsdal
Journal:  Respir Res       Date:  2021-02-05

6.  CA 15-3 prognostic biomarker in SARS-CoV-2 pneumonia.

Authors:  José Antonio Ros-Lucas; Domingo Andrés Pascual-Figal; José Antonio Noguera-Velasco; Álvaro Hernández-Vicente; Iria Cebreiros-López; María Arnaldos-Carrillo; Isabel M Martínez-Ardil; Elisa García-Vázquez; Mario Aparicio-Vicente; Elena Solana-Martínez; Sheyla Yolany Ruiz-Martínez; Laura Fernández-Mula; Rubén Andujar-Espinosa; Beatriz Fernández-Suarez; Maria Dolores Sánchez-Caro; Carlos Peñalver-Mellado; Francisco José Ruiz-López
Journal:  Sci Rep       Date:  2022-04-25       Impact factor: 4.996

Review 7.  Possible Role of Matrix Metalloproteinases and TGF-β in COVID-19 Severity and Sequelae.

Authors:  Gustavo Ramírez-Martínez; Luis Armando Jiménez-Álvarez; Alfredo Cruz-Lagunas; Sergio Ignacio-Cortés; Itzel Alejandra Gómez-García; Tatiana Sofia Rodríguez-Reyna; José Alberto Choreño-Parra; Joaquín Zúñiga
Journal:  J Interferon Cytokine Res       Date:  2022-05-31       Impact factor: 3.657

Review 8.  SARS-CoV-2 and pathological matrix remodeling mediators.

Authors:  Imen Guizani; Nesrine Fourti; Wiem Zidi; Moncef Feki; Monia Allal-Elasmi
Journal:  Inflamm Res       Date:  2021-07-20       Impact factor: 6.986
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.